Cytochrome P-450 polymorphisms and response to clopidogrel Ali J. Marian Clinical Trials Report 18 April 2009 Pages: 157 - 160
A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: Lessons from GOLDN Robert S. Rosenson Clinical Trials Report 18 April 2009 Pages: 161 - 163
Creating a genetic risk score for coronary artery disease Sonny DandonaRobert Roberts OriginalPaper 18 April 2009 Pages: 175 - 181
The paraoxonase gene family and atherosclerosis David SeoPascal Goldschmidt-Clermont OriginalPaper 18 April 2009 Pages: 182 - 187
Proteomics of acute coronary syndromes Athanasios DidangelosDavid SimperManuel Mayr OriginalPaper 18 April 2009 Pages: 188 - 195
Inflammation associated with the postprandial lipolysis of triglyceriderich lipoproteins by lipoprotein lipase Laura J. HigginsJohn C. Rutledge OriginalPaper 18 April 2009 Pages: 199 - 205
Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification Hyun-Ju ChoHyun-Jai ChoHyo-Soo Kim OriginalPaper 18 April 2009 Pages: 206 - 213
Mast cells in atherogenesis: Actions and reactions Petri T. Kovanen OriginalPaper 18 April 2009 Pages: 214 - 219
Lipid raft redox signaling platforms in vascular dysfunction: Features and mechanisms Si JinFan Zhou OriginalPaper 18 April 2009 Pages: 220 - 226
Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease Scott GleimZsolt KaszaJohn Hwa OriginalPaper 18 April 2009 Pages: 227 - 235
The Wnt pathway: A macrophage effector molecule that triggers inflammation Claudia P. PereiraEsther B. BachliGabriele Schoedon OriginalPaper 18 April 2009 Pages: 236 - 242